Karamjeet Singh Sandhu, MD, discusses outcomes from a pooled analysis of the FELIX study in relapsed/refractory B-cell acute lymphoblastic leukemia.
Karamjeet Singh Sandhu, MD
Advertisement
Articles by Karamjeet Singh Sandhu, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer
2
CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma
3
ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma
4
FDA Awards Fast Track Designation to Safusidenib in IDH1-Mutant Glioma
5